Nicholas Investment Partners, LP - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$3,921,000
-30.8%
4,455,836
-2.5%
0.37%
-7.9%
Q1 2022$5,667,000
-32.2%
4,570,387
+6.6%
0.40%
-23.8%
Q4 2021$8,362,000
+9.5%
4,288,077
+53.9%
0.53%
-5.0%
Q3 2021$7,635,000
-12.0%
2,786,354
+1.2%
0.56%
+2.4%
Q2 2021$8,675,000
+88.5%
2,753,880
+27.4%
0.54%
+69.5%
Q1 2021$4,603,0002,161,0020.32%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders